Clinical trial

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus…

NCT00442975 · Public Health England, Other · Completed

Key facts

NCT number NCT00442975
Title Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status
Official title A Phase IV, Single Group Study to Evaluate the Immune Response to Licensed Seasonal Influenza Vaccine and Relationship of This to Cytomegalovirus-associated Immunosenescence in UK Older Adults Aged 50-80 Years
Acronym CMVflu
Lead sponsor Public Health England, Other
Collaborators Royal Free and University College Medical School
Status Completed
Phase Phase 4
Study type Interventional
Conditions Influenza
Intervention type Biological
Interventions Fluarix
Enrollment 100
Start date Mar 1, 2007
Completion Sep 1, 2007
First posted Mar 5, 2007
Last update posted Aug 29, 2018
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies